SEC Form 4 · accession 0001209191-19-015644
STERIS plc · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael B Wood
Director
Period of report
Mar 1, 2019
Accepted (ET)
Mar 4, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001624899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, 10 pence par valueF1 | Mar 1, 2019 | M | 3,609 | $28.08 | A | 25,940 | D | |
| Ordinary Shares, 10 pence par valueF1 | Mar 1, 2019 | S | 3,609 | $121.79 | D | 22,331 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1,F2 | $28.08 | Mar 1, 2019 | M | 3,609 | D | — | Jul 31, 2019 | Ordinary Shares | 3,609 | 0 | D |
Explanation of responses
- F1This stock option exercise and sale of a total of 3,609 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 25, 2017.
- F2This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 3,609 STERIS Corporation common shares for $28.08 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.